A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.

Although largely dominated by grade 2 and 3 patients, the difference in patient outcome for these groups was highly significant ( P = 4.31 × 10 −4 , log-rank test).

also in 132,142 other papers